SCHEMBL7180285

SCHEMBL7180285

COc1cc(OC)c(C(=O)P(=O)(C(=O)c2c(C)cccc2C)c2ccccc2)c(OC)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.44
MAPT P10636 3/20 0.44
CYP3A4 P08684 2/20 0.44
TP53 P04637 1/20 0.44
ATM Q13315 1/20 0.44
HSD17B10 Q99714 1/20 0.44
ALDH1A1 P00352 1/20 0.42
ABCG2 Q9UNQ0 3/20 0.42
MEN1 O00255 4/20 0.41
TSHR P16473 1/20 0.41
USP2 O75604 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
TOP1 P11387 1/20 0.38
PTGS2 P35354 1/20 0.38
TXNRD1 Q16881 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2768729 0.92 KMT2A (0.47) KMT2AMAPTCYP3A4TP53ATM
SCHEMBL7180575 0.92 ABCG2 (0.42) KMT2AMAPTCYP3A4TP53ATM
SCHEMBL7178044 0.91 KMT2A (0.41) KMT2AMAPTCYP3A4TP53ATM
SCHEMBL7188204 0.91 TOP1 (0.39) KMT2AMAPTCYP3A4ATMALDH1A1
SCHEMBL7188964 0.91 MAPT (0.48) KMT2AMAPTCYP3A4TP53ATM
SCHEMBL7189409 0.91 TAS1R3 (0.41) KMT2AMAPTCYP3A4TP53ATM
SCHEMBL7189928 0.90 KMT2A (0.43) KMT2AMAPTCYP3A4TP53ATM
SCHEMBL7175523 0.89 KMT2A (0.43) KMT2AMAPTCYP3A4TP53ATM
SCHEMBL7177382 0.89 CA12 (0.49) KMT2AMAPTCYP3A4ATMALDH1A1
SCHEMBL7179378 0.88 KMT2A (0.41) KMT2AMAPTCYP3A4TP53ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1200943-C Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2005-05-11 CN disclosed
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed
CN-1308081-A Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2001-08-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 KMT2A 1586/4885MAPT 4870/4885CYP3A4 1652/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 KMT2A 956/4885MAPT 4859/4885CYP3A4 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.